mass. Excluding the tumor's location (anterior/posterior), the score categorizes variables that are otherwise continuous in nature to facilitate it. It has not yet been universally adopted at the point of care due to its ambiguity, time consumption, and interobserver variability. We previously showed that the artificial intelligence (AI)-generated R.E.N.A.L. score was non-inferior to the human-generated score in predicting perioperative and oncologic outcomes. We hypothesize that we can surpass the predictive ability of human-generated R.E.N.A.L. scores by creating an AI-generated R.E.N.A.L. scoreþ (AIþ score) with continuous variables rather than ordinal.METHODS: We had 300 patients with preoperative computed tomography scan showing suspected renal cancer at a single institution. Human score was tabulated by 3 trained medical personnel blinded to AI-generated scores. Deep neural network approach was used to automatically segment kidneys into normal parenchyma and tumor, and geometric algorithms were used to estimate the score's components as continuous variables rather than ordinal. Operating characteristic curves (ROC) were created from logistic regression models, and areas under the curve (AUC) were compiled to evaluate the discriminatory ability of the AIþ score vs ordinally-derived AI and human-generated scores for the oncologic outcomes. We assessed the relative importance of the AIþ score components with respect to the odds of outcome through fit logistic regression models using standardized values.RESULTS: The median age was 60 years (IQR 51-68), and 40% were female. The median tumor size was 4.2 cm (2.6-6.12), and 92% were malignant, including 27%, 37%, and 23% with high-stage, high-grade, and necrosis, respectively. The AIþ score had a superior discriminatory ability for each oncologic outcome, including the prediction of malignancy, high stage, high grade, and tumor necrosis (Figure 1). The "R" component had the highest predictive odds ratio for oncologic outcomes.CONCLUSIONS: The AIþ score was superior in predicting meaningful oncologic outcomes compared to ordinal AI-generated and human-generated scores in a non-ambiguous time-efficient manner.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.